Acadia Pharmaceuticals | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
ALKERMES USD 104.84M 79.35M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Corcept Therapeutics USD 9.62M 151.88M 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Eisai JPY -21000000 29.57B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Incyte USD 558.01M 323.82M 2025-06
J&J USD 13.63B 8.21B 2025-03
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Pfizer USD 4.44B 2.36B 2024-12
Prothena USD -59501000 335K 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12


Acadia Pharmaceuticals Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.